Vilamakitug in Spondyloarthritis Placebo-controlled Investigation for Efficacy

Summary

The goal of this clinical trial is to find out if the study drug will work as a new therapy for axSpA patients. This study is placebo-controlled, and evaluates if study drug can treat symptoms of axSpA, including global disease activity, pain, function and inflammation.

Timeline

Start

2026-09

Primary completion

2028-09

Completion

2028-09

Drugs

Indications